Discovery of thienoimidazole-based HCV NS5A genotype 1a and 1b inhibitors

被引:0
|
作者
Giroux, Simon [1 ]
Xu, Jinwang [1 ]
Reddy, T. Jagadeeswar [2 ]
Morris, Mark [1 ]
Cottrell, Kevin M. [1 ]
Cadilhac, Caroline [2 ]
Henderson, James A. [1 ]
Nicolas, Olivier [3 ]
Bilimoria, Darius [3 ]
Mani, Nagraj [4 ]
Ewing, Nigel [5 ]
Shawgo, Rebecca [5 ]
L'Heureux, Lucille [3 ]
Selliah, Subajini [3 ]
Grillot, Anne-Laure [1 ]
Bennani, Youssef L. [2 ]
Maxwell, John P. [1 ]
机构
[1] Vertex Pharmaceut, Med Chem, Boston, MA 02210 USA
[2] Vertex Pharmaceut Canada Inc, Med Chem, Laval, PQ H7V 4A7, Canada
[3] Vertex Pharmaceut Canada Inc, Biol, Laval, PQ H7V 4A7, Canada
[4] Vertex Pharmaceut, Biol, Boston, MA 02210 USA
[5] Vertex Pharmaceut, Drug Metab & Pharmacokinet, Boston, MA 02210 USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 248卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
79-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [41] VALIDATION OF THE GENESEQ™ HCV NS5B SEQUENCING ASSAY FOR PATIENT-DERIVED HCV SUBTYPES 1A AND 1B
    Choe, S.
    Han, D.
    Cheng, M.
    Anton, E.
    Stawiski, E.
    Penuel, E.
    Parkin, N.
    Petropoulos, C. J.
    Reeves, J. D.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S298 - S298
  • [42] Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens
    Akuta, Norio
    Sezaki, Hitomi
    Suzuki, Fumitaka
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Suzuki, Yoshiyuki
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (07) : 1248 - 1254
  • [43] Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR development
    Nair, Anilkumar G.
    Zeng, Qingbei
    Selyutin, Oleg
    Rosenblum, Stuart B.
    Jiang, Yueheng
    Yang, De-Yi
    Keertikar, Kerry
    Zhou, Guowei
    Dwyer, Michael P.
    Kim, Seong Heon
    Shankar, Bandarpalle
    Yu, Wensheng
    Tong, Ling
    Chen, Lei
    Mazzola, Robert
    Caldwell, John
    Tang, Haiqun
    Allard, Melissa L.
    Buckle, Ronald N.
    Gauuan, Polivina Jolicia F.
    Holst, Christian L.
    Martin, Gregory S.
    Naicker, Kannan P.
    Vellekoop, Samuel
    Agrawal, Sony
    Liu, Rong
    Kong, Rong
    Ingravallo, Paul
    Xia, Ellen
    Zhai, Ying
    Nomeir, Amin
    Kozlowski, Joseph A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (05) : 1475 - 1479
  • [44] CHARACTERIZATION OF A MAJOR V3 DUPLICATION IN THE NS5A REGION OF GENOTYPE 1B HCV BY QUASISPECIES ANALYSIS IN A FRENCH MULTICENTER STUDY
    Le Guillou-Guillemette, H.
    Bouthry, E.
    Pivert, A.
    Rosenberg, A.
    Alain, S.
    Thibault, V.
    Abravanel, F.
    Minjolle-Cha, S.
    Andre-Garnier, E.
    Moradpour, D.
    Henquell, C.
    Bour, J. -B.
    Petsaris, O.
    Baazia, Y.
    Andre, P.
    Trimoulet, P.
    Gaudy-Graffin, C.
    Bettinger, D.
    Saoudin, H.
    Schvoerer, E.
    Izopet, J.
    Payan, C.
    Lunel-Fabiani, F.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S322 - S322
  • [45] Distinct Evolutionary Pathways of NS5A Inhibitor Resistance in Patients With Genotype 1a Versus 1b Infection During Monotherapy With MK-8742 (Elbasvir)
    Williford, Sara
    Zhou, Shuntai
    Burch, Christina
    Asante-Appiah, Ernest
    Howe, Anita
    Swanstrom, Ronald
    Lemon, Stanley M.
    HEPATOLOGY, 2016, 64 : 103A - 103A
  • [46] Discovery of silyl proline containing HCV NS5A inhibitors: SAR development
    Kozlowski, Joseph
    Anilkumar, Nair
    Selyutin, Oleg
    Rosenblum, Stuart
    Jiang, Yueheng
    Yang, De-Yi
    Keertikar, Kerry
    Zhou, Guowei
    Dwyer, Michael
    Kim, Seong Heon
    Shankar, Bandarpalle
    Yu, Wensheng
    Tong, Ling
    Mazzola, Robert
    Caldwell, John
    Tang, Haiqun
    Agrawal, Sony
    Asante-Appiah, Ernest
    Curry, Stephanie
    McMonagle, Patricia
    Black, Stuart
    Nomeir, Amin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [47] The prevalence of naturally occurring resistance mutations against NS3 protease inhibitors, NS5A replication complex inhibitors, and NS5B polymerase inhibitors in patients with hepatitis C virus genotype 1b
    Hayashi, Kazuhiko
    Ishigami, Masatoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Katano, Yoshiaki
    Hirooka, Yoshiki
    Goto, Hidemi
    HEPATOLOGY, 2014, 60 : 896A - 897A
  • [48] HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A
    Ken-ichi Abe
    Masanori Ikeda
    Yasuo Ariumi
    Hiromichi Dansako
    Takaji Wakita
    Nobuyuki Kato
    Archives of Virology, 2009, 154 : 1671 - 1677
  • [49] HCV genotype 1b chimeric replicon with NS5B of JFH-1 exhibited resistance to cyclosporine A
    Abe, Ken-ichi
    Ikeda, Masanori
    Ariumi, Yasuo
    Dansako, Hiromichi
    Wakita, Takaji
    Kato, Nobuyuki
    ARCHIVES OF VIROLOGY, 2009, 154 (10) : 1671 - 1677
  • [50] Prevalence of hepatitis C virus (HCV) variants resistant to NS5A inhibitors in naive patients infected with HCV genotype 1 in Tunisia
    Larousse, Jameleddine Aissa
    Trimoulet, Pascale
    Pinson, Patricia Recordon
    Tauzin, Brigitte
    Azzouz, Mohamed Mssadak
    Ben Mami, Nabyl
    Cheikh, Imed
    Triki, Henda
    Fleury, Herve
    VIROLOGY JOURNAL, 2015, 12